Christophe Taoum, MD, PhD. Surgical oncologist at the Montpellier Cancer Institute (ICM), France. PhD in collaboration with M2iSH laboratory, focused on the identification of biomarkers associated with neoadjuvant treatment response, with a particular emphasis on colibactin-producing Escherichia coli in patients with mid or low rectal cancer.